Younggil Kwon

510 total citations
11 papers, 385 citations indexed

About

Younggil Kwon is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Molecular Biology. According to data from OpenAlex, Younggil Kwon has authored 11 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pediatrics, Perinatology and Child Health, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Younggil Kwon's work include Drug Transport and Resistance Mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Glycogen Storage Diseases and Myoclonus (2 papers). Younggil Kwon is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Glycogen Storage Diseases and Myoclonus (2 papers). Younggil Kwon collaborates with scholars based in United States and Denmark. Younggil Kwon's co-authors include Marilyn E. Morris, Amrita V. Kamath, Judith L. Treadway, JoAnn D. Bradley, Mark K. Wedel, Tanya Watanabe, Richard S. Geary, Jan Jaap van Lier, Per Vestergaard and Jeremy C. Parker and has published in prestigious journals such as Diabetes, Journal of Lipid Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Younggil Kwon

11 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Younggil Kwon United States 9 148 106 73 39 35 11 385
Graham Somers United Kingdom 13 108 0.7× 67 0.6× 93 1.3× 47 1.2× 11 0.3× 17 545
Takashi Igarashi Japan 11 197 1.3× 61 0.6× 111 1.5× 19 0.5× 12 0.3× 26 425
David W. Alberts United States 10 131 0.9× 59 0.6× 48 0.7× 81 2.1× 25 0.7× 11 372
Lolita C. Rodriguez United States 9 172 1.2× 37 0.3× 64 0.9× 93 2.4× 27 0.8× 15 390
Noriko Masubuchi Japan 13 161 1.1× 168 1.6× 142 1.9× 23 0.6× 9 0.3× 17 450
Aiji Miyashita Japan 11 127 0.9× 103 1.0× 178 2.4× 68 1.7× 30 0.9× 20 451
Appavu Chandrasekaran United States 15 178 1.2× 82 0.8× 92 1.3× 54 1.4× 6 0.2× 43 595
Miao Hu China 14 100 0.7× 167 1.6× 65 0.9× 24 0.6× 18 0.5× 24 523
Moti Rosenstock Israel 13 256 1.7× 43 0.4× 48 0.7× 74 1.9× 14 0.4× 19 574
Glenda J. Moser United States 15 199 1.3× 52 0.5× 47 0.6× 27 0.7× 94 2.7× 29 678

Countries citing papers authored by Younggil Kwon

Since Specialization
Citations

This map shows the geographic impact of Younggil Kwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Younggil Kwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Younggil Kwon more than expected).

Fields of papers citing papers by Younggil Kwon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Younggil Kwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Younggil Kwon. The network helps show where Younggil Kwon may publish in the future.

Co-authorship network of co-authors of Younggil Kwon

This figure shows the co-authorship network connecting the top 25 collaborators of Younggil Kwon. A scholar is included among the top collaborators of Younggil Kwon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Younggil Kwon. Younggil Kwon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Ercan-Fang, Nacide, Judith L. Treadway, E. Michael Gibbs, et al.. (2005). Endogenous effectors of human liver glycogen phosphorylase modulate effects of indole-site inhibitors. American Journal of Physiology-Endocrinology and Metabolism. 289(3). E366–E372. 14 indexed citations
3.
Harwood, H. James, Stephen F. Petras, Dennis J. Hoover, et al.. (2004). Dual-action hypoglycemic and hypocholesterolemic agents that inhibit glycogen phosphorylase and lanosterol demethylase. Journal of Lipid Research. 46(3). 547–563. 15 indexed citations
4.
Kwon, Younggil. (2002). Handbook of Essential Pharmacokinetics, Pharmacodynamics and Drug Metabolism for Industrial Scientists. Kluwer Academic Publishers eBooks. 196 indexed citations
5.
Parker, Jeremy C., Maria A. VanVolkenburg, William H. Martin, et al.. (1998). Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.. Diabetes. 47(10). 1630–1636. 45 indexed citations
7.
Kwon, Younggil & Marilyn E. Morris. (1997). Membrane Transport in Hepatic Clearance of Drugs II: Zonal Distribution Patterns of Concentration-Dependent Transport and Elimination Processes. Pharmaceutical Research. 14(6). 780–785. 13 indexed citations
8.
Kwon, Younggil, Amrita V. Kamath, & Marilyn E. Morris. (1996). Inhibitors of P-Glycoprotein-Mediated Daunomycin Transport in Rat Liver Canalicular Membrane Vesicles. Journal of Pharmaceutical Sciences. 85(9). 935–939. 28 indexed citations
9.
Kwon, Younggil, et al.. (1996). Theoretical Considerations on Two Equations for Estimating the Extent of Absorption After Oral Administration of Drugs. Pharmaceutical Research. 13(4). 566–569. 8 indexed citations
10.
Kwon, Younggil, et al.. (1996). Hepatic uptake of choline in rat liver basolateral and canalicular membrane vesicle preparations.. Journal of Pharmacology and Experimental Therapeutics. 279(2). 774–781. 10 indexed citations
11.
Kwon, Younggil & Marilyn E. Morris. (1995). Hepatic Membrane Transport of Organic Cations Using Isolated Rat Hepatocyte Membrane Vesicles: Structure–Transport Relationships. Pharmaceutical Research. 12(7). 1109–1114. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026